We are live on ! Find out more
NXTM

NxStage Medical Inc.
NXTM

Delisted

NXTM was delisted on the 21st of February, 2019.

140 hedge funds and large institutions have $913M invested in NxStage Medical Inc. in 2016 Q1 according to their latest regulatory filings, with 26 funds opening new positions, 57 increasing their positions, 40 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed

320% more call options, than puts

Call options by funds: $2.22M | Put options by funds: $528K

43% more repeat investments, than reductions

Existing positions increased: 57 | Existing positions reduced: 40

4% more first-time investments, than exits

New positions opened: 26 | Existing positions closed: 25

0% more funds holding

Funds holding: 140140 (0)

29% less funds holding in top 10

Funds holding in top 10: 75 (-2)

30% less capital invested

Capital invested by funds: $1.3B → $913M (-$383M)

Holders
140
Holders Change
Holders Change %
0%
% of All Funds
3.73%
Holding in Top 10
5
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-28.57%
% of All Funds
0.13%
New
26
Increased
57
Reduced
40
Closed
25
Calls
$2.22M
Puts
$528K
Net Calls
+$1.69M
Net Calls Change
-$1.78M
Name Holding Trade Value Shares
Change
Change in
Stake
SC
151
Skylands Capital
Wisconsin
-$686K -31,300 Closed
CPA
152
Columbia Pacific Advisors
Washington
-$657K -30,000 Closed
AW
153
Alpha Windward
Massachusetts
-$485K -22,140 Closed
RCM
154
Rotella Capital Management
Washington
-$484K -22,100 Closed
RJA
155
Raymond James & Associates
Florida
-$268K -12,228 Closed
PG
156
PEAK6 Group
Illinois
-$266K -12,149 Closed
ST
157
Spot Trading
Illinois
-$210K -9,600 Closed
ProShare Advisors
158
ProShare Advisors
Maryland
-$202K -9,205 Closed
CCM
159
Cupps Capital Management
Illinois
-$81K -3,700 Closed
FMA
160
FNY Managed Accounts
New York
-$32.9K -1,500 Closed
PCM
161
Prelude Capital Management
New York
-$29K -1,343 Closed
JP Morgan Chase
162
JP Morgan Chase
New York
-$5K -238 Closed
Creative Planning
163
Creative Planning
Kansas
-$4K -200 Closed
KCPG
164
Kavar Capital Partners Group
Kansas
-$1K -81 Closed

NXTM Hedge Fund Activity: Q1 2016 in Review

140 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in NxStage Medical Inc. (NXTM) for Q1 2016, worth a combined $913M — down 30% from $1.3B a quarter earlier.

Buyers outnumbered sellers: 26 funds opened new NXTM positions and 25 closed out — a net gain of 1 holder — while 57 added to existing stakes and 40 trimmed.

The largest buyer was Fidelity Investments, adding an estimated $19.7M. The largest seller was RS Investment Management, cutting an estimated $10M.

  • 140 institutional investors held NxStage Medical Inc. (NXTM) as of Q1 2016, unchanged from Q4 2015.
  • Funds reported $913M of NxStage Medical Inc. stock for Q1 2016, down 30% quarter-over-quarter.
  • 26 funds opened new NxStage Medical Inc. positions in Q1 2016 and 25 closed out, a net change of +1 holder.
  • The largest NxStage Medical Inc. buyer in Q1 2016 was Fidelity Investments, an estimated $19.7M added.
  • The largest NxStage Medical Inc. seller in Q1 2016 was RS Investment Management, an estimated $10M sold.

Based on aggregated 13F filings for Q1 2016.